Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more.

Choose a country



    Softgel Fills – Find the right fill for your Softgel formulation needs

    At BASF we offer a comprehensive range of high quality functional excipients, vitamins and omega-3 fish oils to support you in finding the right capsule fill for your formulation needs. This unique combination of products builds a bridge between dietary supplements and pharmaceutical products.

    Benefits
    Leading in softgel fills with a broad portfolio from Omega-3, to Vitamins and functional excipients
    Extensive expertise in softgel technology through Omega-3 Verbund
    Unique combination of products building a bridge between dietary supplements and pharmaceutical products
    Extensive expertise in oleochemicals and polymer chemistry
    Hydrophilic fills of the highest purity to minimize gelatin crosslinking and API reactions

    Solvents and Fills:

    From dietary supplements to complex self-emulsifying drug delivery systems for the formulation of poorly soluble APs. At BASF we offer a comprehensive range of high quality functional excipients, vitamins and omega-3 fish oils to support you in finding the right capsule fill for your formulation needs. This unique combination of products builds a bridge between dietary supplements and pharmaceutical products. Furthermore, all ingredients have been tested according to the highest quality standards to minimize the possibility of crosslinking.

    Omega-3 Verbund - expertise in softgel formulations

    BASF is the pioneer in omega-3, with its foundations in Norway in 1838. We are world leader in high-concentrate omega-3 fatty acids for pharmaceuticals, dietary supplements and clinical nutrition categories. Our leadership is built on a global customer reach, R&D capabilities for lipids, omega-3 derivates and development of omega-3 fatty acid formulations, and an unrivalled worldwide safety and efficacy data on omega-3 softgel drugs such as Omacor®, Lovaza, Lotriga®, Zodin®.

    Omega 3

    - Extensive expertise in softgel technology through Omega 3 Verbund
    - Hydrophilic fills of the highest purity to minimize gelatin crosslinking and API reactions
    - Compliance with all regulatory requirements
    - Pioneering in Omega 3 since 1838

    Solubilization enhancement and emulsification

    More and more drugs in development exhibit low solubility. Therefore, poorly soluble drugs are one of the major challenges pharmaceutical manufacturers are facing. Self-emulsifying drug delivery is one option enhance solubility and bioavailability for lipophilic drug. BASF offers a comprehensive range of high quality solubilizers, lipids and solvents for this challenge. Finding the right combination of emulsifier, co-emulsifier and solvent for a self-emulsifying drug delivery system has been traditionally a trial and error approach; BASF can offer high throughput screening tools in order to speed up formulation time.

    Crystallization inhibition for enhanced bioavailability

    Crystallization inhibition is an important factor to maintain drug solubility and bioavailability out of solid and liquid dosage forms in particular. Before it can be adsorbed, recrystallization can happen at any point in time after formulation, during storage or administration, causing bioavailability to plummet and a consequent loss of medication efficacy. BASF offers a range of well established crystallization inhibitors that ensure that your drug will not get lost on its way to the point of action in the body, i.e. our low molecular weight povidones Kollidon® 12 PF and Kollidon® 17 PF or our Kollicoat® MAE 100-55.

    Product Overview

    Focusing on your needs with platform solutions

    This brochure presents an overview of our leading-edge products, grouped in the following platforms: Softgels, Instant and Modified Release, ...

    TOP